Structure-Guided DOT1L Probe Optimization by Label-Free Ligand Displacement

[Image: see text] The DOT1L lysine methyltransferase has emerged as a validated therapeutic target in MLL-rearranged (MLLr) acute leukemias. Although S-adenosylmethionine competitive inhibitors have demonstrated pharmacological proof-of-principle in MLLr-leukemia, these compounds require further opt...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Joanna S., Federation, Alexander J., Qi, Jun, Dhe-Paganon, Sirano, Hadler, Michael, Xu, Xiang, St. Pierre, Roodolph, Varca, Anthony C., Wu, Lei, Marineau, Jason J., Smith, William B., Souza, Amanda, Chory, Emma J., Armstrong, Scott A., Bradner, James E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504433/
https://www.ncbi.nlm.nih.gov/pubmed/25397901
http://dx.doi.org/10.1021/cb500796d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504433/
https://www.ncbi.nlm.nih.gov/pubmed/25397901
http://dx.doi.org/10.1021/cb500796d

Ejemplares similares